Tilray CEO Brendan Kennedy proclaims "medical cannabis is disrupting Big Pharma."
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
